Literature DB >> 15013736

The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.

H P Duerr1, K Dietz, H Schulz-Key, D W Büttner, M Eichner.   

Abstract

We investigate the relationship between the microfilarial density in the skin and the burden of adult female Onchocerca volvulus by analysing pre-control nodulectomy data which allow for a direct approach, independent of exposure. The data of 169 patients in Burkina Faso and 182 patients in Liberia represent savannah and forest onchocerciasis in West Africa, respectively. Whereas in Burkina Faso, a saturating relationship between microfilarial density and worm burden suggests the operation of density-dependent processes within human hosts, the Liberian data show a linear relationship implying no density dependence. The differences may derive from differences between both parasite strains, i.e. the savannah or the forest strain of O. volvulus. Consistently for both parasite strains and independent of the worm burden, the microfilarial density increases with host age emphasising the concept of the acquisition of immunological tolerance. In male hosts in Liberia, the microfilarial density increases stronger with the worm burden than in female hosts, whereas such sex-specific differences cannot be found in Burkina Faso. In the methodological part of this investigation, we suggest the beta-distribution to be most appropriate for describing variability in microfilarial densities and we present an approach to consider the uncertainty in the adult parasite burden which cannot be determined precisely in helminth infections. Implications of density dependence are discussed with respect to immunological processes in the human host and with respect to the success of control programs. The relationships described show that regulatory processes between the parasite and the human host are multi-dimensional, operating within a high degree of biological variability.

Entities:  

Mesh:

Year:  2004        PMID: 15013736     DOI: 10.1016/j.ijpara.2003.11.008

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  14 in total

1.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

2.  Human infection patterns and heterogeneous exposure in river blindness.

Authors:  João A N Filipe; Michel Boussinesq; Alfons Renz; Richard C Collins; Sarai Vivas-Martinez; María-Eugenia Grillet; Mark P Little; María-Gloria Basáñez
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

3.  Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis.

Authors:  Lisa Luu; Germanus S Bah; Ndode Herman Okah-Nnane; Catherine S Hartley; Alexandra F Glover; Tessa R Walsh; Lu-Yun Lian; Bin Zhan; Maria Elena Bottazzi; David Abraham; Nikolai Petrovsky; Nicolas Bayang; Bernard Tangwa; Rene Billingwe Ayiseh; Glory Enjong Mbah; David D Ekale; Vincent N Tanya; Sara Lustigman; Benjamin L Makepeace; John Graham-Brown
Journal:  Vaccines (Basel)       Date:  2022-05-27

4.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 5.  Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.

Authors:  Christoph Kaiser; Sébastien D S Pion; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

Review 6.  A research agenda for helminth diseases of humans: modelling for control and elimination.

Authors:  María-Gloria Basáñez; James S McCarthy; Michael D French; Guo-Jing Yang; Martin Walker; Manoj Gambhir; Roger K Prichard; Thomas S Churcher
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

7.  Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

Authors:  Luc E Coffeng; Wilma A Stolk; Achim Hoerauf; Dik Habbema; Roel Bakker; Adrian D Hopkins; Sake J de Vlas
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

8.  Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.

Authors:  Christian Bottomley; Valerie Isham; Sarai Vivas-Martínez; Annette C Kuesel; Simon K Attah; Nicholas O Opoku; Sara Lustigman; Martin Walker; Maria-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2016-06-14       Impact factor: 3.876

9.  Disturbances, organisms and ecosystems: a global change perspective.

Authors:  Jean-François Ponge
Journal:  Ecol Evol       Date:  2013-03-06       Impact factor: 2.912

10.  A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.

Authors:  Kwablah Awadzi; Nicholas O Opoku; Simon K Attah; Janis Lazdins-Helds; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.